Ireland - English - HPRA (Health Products Regulatory Authority)

bayer limited - nifedipine atenolol - capsule - 20mg/50 mg milligram

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - nifedipine - tablet, film coated - 60 mg - nifedipine 60 mg

Singapore - English - HSA (Health Sciences Authority)

bayer (south east asia) pte ltd - nifedipine - tablet, film coated - 30 mg - nifedipine 30 mg

Ireland - English - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - nifedipine - prolonged-release tablet - 20 milligram(s) - dihydropyridine derivatives; nifedipine

Ireland - English - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - nifedipine - prolonged-release tablet - 60 milligram(s) - dihydropyridine derivatives; nifedipine

Ireland - English - HPRA (Health Products Regulatory Authority)

imed healthcare ltd. - nifedipine - prolonged-release tablet - 30 milligram(s) - dihydropyridine derivatives; nifedipine

Ireland - English - HPRA (Health Products Regulatory Authority)

b & s healthcare - nifedipine - tablet prolonged release - 20 milligram

Malta - English - Medicines Authority

bayer plc - nifedipine - prolonged-release tablet - nifedipine 30 mg - calcium channel blockers

United States - English - NLM (National Library of Medicine)

almatica pharma inc. - nifedipine (unii: i9zf7l6g2l) (nifedipine - unii:i9zf7l6g2l) - nifedipine 30 mg - concomitant administration with strong p450 inducers, such as rifampin, are contraindicated since the efficacy of nifedipine tablets could be significantly reduced. (see precautions, drug interactions .)  nifedipine must not be used in cases of cardiogenic shock. adalat is contraindicated in patients with a known hypersensitivity to any component of the tablet.

United Kingdom - English - MHRA (Medicines & Healthcare Products Regulatory Agency)

bayer plc - nifedipine - modified-release tablet - 60mg